M32.19

M32.19 captures systemic lupus erythematosus with documented involvement of an organ or system not individually named in codes M32.11–M32.15 — covering manifestations such as neuropsychiatric (lupus encephalitis), musculoskeletal, hematologic, dermatologic, hepatic, or ocular involvement when those specific sites lack a dedicated subcategory.

Verified May 8, 2026 · 6 sources ↓

Status: Billable
Chapter: 13
Related CPT: 5
Region: General

Drawn from CDCICD10DataAAPCUnboundmedicineOutsourcestrategies

Documentation tips

What should appear in the chart to support M32.19.

Source · Editorial brief grounded in 6 cited references ↓

Explicitly name the organ or system involved in the assessment — 'SLE with musculoskeletal involvement' or 'SLE with neuropsychiatric manifestations' — not just 'SLE flare.'
Assign the required additional code identifying the specific manifestation (e.g., G05.3 for encephalitis, M06.9 for inflammatory arthropathy) per the tabular 'Use Additional Code' instruction.
Record supporting lab findings: ANA titer, anti-dsDNA, complement levels (C3/C4), CBC with differential, ESR/CRP — these establish inflammatory activity and medical necessity.
Document whether the involvement is new, ongoing, or worsening to support medical decision-making complexity and justify the visit level.
If steroid therapy is a factor (e.g., AVN risk), note the medication and duration in the record — it may trigger additional codes for drug-related conditions.

Related CPT procedures

Procedure codes commonly billed with M32.19. Linking the right diagnosis to the right procedure is what establishes medical necessity.

Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis

99213 $95.19

Established patient office or outpatient visit requiring 20–29 minutes of total time or low-complexity medical decision-making.

99214 $135.61

Office visit for an established patient requiring moderate-complexity medical decision making (MDM), or 30–39 minutes of total provider time on the date of service.

99215 $192.39

Highest-level office or outpatient E/M visit for an established patient, qualifying via high-complexity medical decision making or 40–54 minutes of total provider time on the date of service.

20610 $68.81

Aspiration and/or injection of a major joint or bursa (shoulder, hip, knee, or subacromial bursa) performed without ultrasound guidance.

96372 View procedure details

Common coding pitfalls

The recurring mistakes coders make with M32.19 and adjacent codes.

Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓

Defaulting to M32.9 (unspecified SLE) when organ involvement is clearly documented — M32.9 is only correct when no involvement is established.
Using M32.10 (organ/system involvement unspecified) when the system is actually named in the note — M32.10 is for genuinely incomplete workups, not a safe default.
Failing to add the required secondary code for the specific manifestation (e.g., G05.3, M06.9) — M32.19 alone does not fully capture the encounter and may trigger a medical necessity query.
Applying M32.19 for lupus nephritis — glomerular disease maps to M32.14 and tubulo-interstitial nephropathy to M32.15; those codes take precedence over M32.19 for renal involvement.
Confusing M32.19 with M32.8 (other forms of SLE) — M32.8 applies when the nature or form of the lupus itself is uncertain, not when a specific organ is involved.

Clinical context

Source · Editorial summary grounded in 6 cited references ↓

Use M32.19 when the patient's SLE has confirmed, documented organ or system involvement that falls outside the five explicitly named subcategories: endocarditis (M32.11), pericarditis (M32.12), lung involvement (M32.13), glomerular disease (M32.14), and tubulo-interstitial nephropathy (M32.15). Common scenarios include lupus cerebritis or encephalitis, lupus arthritis/myositis, cytopenias, serositis beyond pericarditis, hepatic involvement, and cutaneous vasculitis in the setting of confirmed systemic disease. The tabular instruction requires an additional code to identify the specific organ or system manifestation — for example, G05.3 for lupus encephalitis.

M32.19 is not a fallback for incomplete workups. If the organ system is documented but workup is still ongoing, use M32.10 (organ or system involvement unspecified). Reserve M32.19 for encounters where the clinician has identified and documented the specific involved system, even if that system doesn't map to M32.11–M32.15. M32.9 (SLE unspecified) is appropriate only when no organ involvement is documented at all.

For orthopedic coders specifically: when SLE drives a musculoskeletal encounter — joint pain, inflammatory arthropathy, avascular necrosis from steroid use, or myopathy — M32.19 is the correct SLE-with-involvement code, paired with the additional musculoskeletal or joint-specific code. Do not default to M32.9 simply because the visit is orthopedic.

Sibling codes

Other billable codes under M32.1 (laterality / anatomic variants).

M32.14

Glomerular disease in systemic lupus erythematosus

M32.12

Pericarditis in systemic lupus erythematosus

M32.10

Systemic lupus erythematosus, organ or system involv unsp

M32.11

Endocarditis in systemic lupus erythematosus

M32.15

Tubulo-interstitial nephrop in sys lupus erythematosus

M32.13

Lung involvement in systemic lupus erythematosus

Frequently asked questions

Source · Generated from the editorial pipeline, verified against 6 cited references ↓

01When does M32.19 apply versus M32.9?

M32.9 is correct only when SLE is documented with no organ or system involvement. Once the clinician names an involved system — joints, CNS, blood, liver, skin — use M32.19 (or a more specific subcategory if one exists).

02Does M32.19 require a secondary code?

Yes. The ICD-10-CM tabular includes a 'Use Additional Code' instruction to identify the specific organ or system involvement, such as G05.3 for lupus encephalitis. Submitting M32.19 alone is technically incomplete.

03Can I use M32.19 for lupus nephritis?

No. Glomerular disease in SLE maps to M32.14 and tubulo-interstitial nephropathy to M32.15. Those specific codes take priority. Use M32.19 only when the renal involvement type does not fit M32.14 or M32.15, which is uncommon.

04What is the difference between M32.19 and M32.10?

M32.10 means the clinician knows organ involvement exists but cannot yet specify which system — appropriate when workup is incomplete. M32.19 means a specific system is involved and documented, just not one covered by M32.11–M32.15.

05Is M32.19 appropriate for an orthopedic encounter driven by SLE joint disease?

Yes. SLE-related arthropathy, myopathy, or avascular necrosis presenting at an orthopedic visit should be coded M32.19 plus the specific musculoskeletal code. Do not drop to M32.9 because the setting is orthopedic.

06Can M32.19 and a specific organ code both appear on the same claim?

Yes — that is the intended coding pattern. M32.19 identifies the SLE with involvement; the additional code (e.g., G05.3, M06.9, D59.0) identifies the manifestation. Both should appear on the claim to fully represent the encounter.

07What distinguishes M32.19 from M32.8?

M32.8 (other forms of SLE) applies when the provider is uncertain about the nature or subtype of the lupus itself. M32.19 is used when the SLE diagnosis is confirmed and a specific organ system outside M32.11–M32.15 is involved.

Sources & references

Editorial content was developed using the following public sources. Last verified May 8, 2026.

Mira AI Scribe

The Mira AI Scribe captures the treating clinician's explicit statement of which organ or system is involved — musculoskeletal, neuropsychiatric, hematologic, hepatic, dermatologic — along with supporting labs (ANA, anti-dsDNA, complement, CBC), physical exam findings, and current disease activity. That specificity locks in M32.19 over the weaker M32.9 or M32.10 and ensures the required additional manifestation code is populated, preventing downcoding and payer medical necessity denials.

See how Mira captures M32.19 documentation